1. Home
  2. EPM vs ARMP Comparison

EPM vs ARMP Comparison

Compare EPM & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evolution Petroleum Corporation Inc.

EPM

Evolution Petroleum Corporation Inc.

HOLD

Current Price

$4.49

Market Cap

158.2M

Sector

Energy

ML Signal

HOLD

ARMP

Armata Pharmaceuticals Inc.

HOLD

Current Price

$9.75

Market Cap

383.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EPM
ARMP
Founded
2003
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
158.2M
383.7M
IPO Year
1996
1996

Fundamental Metrics

Financial Performance
Metric
EPM
ARMP
Price
$4.49
$9.75
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$4.93
$15.00
AVG Volume (30 Days)
412.9K
40.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
10.46%
N/A
EPS Growth
N/A
53.40
EPS
0.05
N/A
Revenue
$43,229,621.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$92.20
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.19
$0.90
52 Week High
$5.70
$13.75

Technical Indicators

Market Signals
Indicator
EPM
ARMP
Relative Strength Index (RSI) 53.70 50.10
Support Level $4.38 $5.14
Resistance Level $4.63 $12.11
Average True Range (ATR) 0.16 0.96
MACD -0.02 -0.27
Stochastic Oscillator 37.17 17.65

Price Performance

Historical Comparison
EPM
ARMP

About EPM Evolution Petroleum Corporation Inc.

Evolution Petroleum Corp is an independent energy company focused on owning and investing in onshore oil and natural gas properties across the United States. Its portfolio includes non-operated interests in various production fields such as CO2 enhanced oil recovery in Louisiana, secondary recovery production in Wyoming, and shale gas reservoirs in Texas and North Dakota. The company generates revenue from the production and sale of oil and natural gas, leveraging specialized technologies to extend reservoir life and enhance recoveries.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

Share on Social Networks: